HIV Lipodystrophy

11 registered clinical trials studyying HIV Lipodystrophy.

Status	Trial	Sponsor	Phase
Completed	The Visceral Adiposity Measurement and Observation Study NCT05383456	Theratechnologies	—
Unknown	Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Dis NCT04903847	Thomas Benfield	Phase 4
Completed	Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected In NCT04904406	Thomas Benfield	Phase 4
Completed	Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults NCT03039491	Medical University of South Carolina	EARLY_Phase 1
Terminated	Effects of IGF-I in HIV Metabolic Disease NCT01329744	University of Texas Southwestern Medical Center	Phase 1
Completed	Effects of Growth Hormone Releasing Hormone in HIV NCT01263717	Massachusetts General Hospital	N/A
Completed	Effects of Short-term Growth Hormone in HIV-infected Patients NCT00795210	Massachusetts General Hospital	N/A
Completed	Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome NCT00362440	Beth Israel Deaconess Medical Center	Phase 2
Completed	Yoga for the Management of HIV-Metabolic Syndromes NCT00627380	Washington University School of Medicine	Phase 4
Completed	Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome NCT00656851	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	N/A
Completed	Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome NCT01511016	Baylor College of Medicine	N/A